Digital health has been one of the hottest terms of the last decade and will be even more so in the future. Digital health technologies can empower consumers to make informed choices about their own health and provide new options to health care professionals in terms of disease prevention, diagnosis and management. This is providing new opportunities to MedTech companies and other stakeholders in the field, but also implies many challenges: regulatory, data governance, market access, technical, legal, ethical, etc.
The committee involves 340+ members from 85+ MedTech companies (large MNCs, SMEs, start-ups), organised in 4 working groups with the following objectives:
Digital Health Market by Precedence Research
Objectives of the Digital Health Functional Committee:
*Companies in scope are APACMed corporate members, i.e. manufacturing and conducting R&D in medical equipment, devices, in-vitro diagnostics, or digital health solutions with global annual sales above USD 50 million ** Last updated April 2021